Characteristics of the Cajal interstitial cells and intestinal microbiota in children with refractory constipation

Yi Yuan1, Yan Lu2, Zhihua Zhang2

  • 1Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China.

Microbial Pathogenesis
|September 28, 2023
PubMed

Insights

Children with refractory constipation exhibit reduced colonic motility and altered interstitial cells of Cajal (ICCs). Intestinal microbiota composition significantly differs in these patients, suggesting new therapeutic targets for this condition.

Area of Science:

  • Pediatric Gastroenterology
  • Colorectal Surgery
  • Microbiome Research

Background:

  • Refractory constipation significantly impacts children's quality of life.
  • The underlying pathophysiology of pediatric refractory constipation is not fully understood.

Purpose of the Study:

  • To investigate colonic motor patterns, interstitial cells of Cajal (ICCs), and intestinal microbiota in children with refractory constipation.

Main Methods:

  • Colonic manometry (CM) assessed motility in 30 children.
  • Colon biopsies analyzed ICCs via immunohistochemistry.
  • 16S rRNA sequencing profiled fecal microbiota in 14 patients and 28 controls.

Main Results:

  • Dysmotility group (n=20) showed lower colonic motility and impaired postprandial response compared to the normal group (n=10).
  • ICCs exhibited altered number, distribution, and morphology in refractory constipation patients.
  • Significant differences in intestinal microbiota composition were observed, with decreased Faecalibacterium and increased Parabacteroides and Alistipes in affected children.

Conclusions:

  • Reduced colonic motility and ICC abnormalities contribute to refractory constipation pathogenesis.
  • Distinct gut microbiota profiles in affected children offer potential therapeutic avenues.
  • Findings provide insights for novel treatment strategies for pediatric refractory constipation.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
181
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.6K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
197
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
304
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
474
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
422